- Home
- KITT vs TOVX Comparison
KITT vs TOVX Comparison
Compare KITT & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KITT | TOVX |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 6.5M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | KITT | TOVX |
|---|---|---|
| Price | $0.76 | $0.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.2M | 2.1M |
| Earning Date | 11-14-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,688,840.00 | N/A |
| Revenue This Year | $2,936.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 95.38 | N/A |
| 52 Week Low | $0.69 | $0.17 |
| 52 Week High | $15.21 | $1.75 |
Technical Indicators
Market Signals| Indicator | KITT | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 44.84 |
| Support Level | $0.82 | $0.18 |
| Resistance Level | $1.06 | $0.21 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 2.22 | 28.00 |
Price Performance
Historical ComparisonAbout KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.